May 30, 2023
More on Pharmacy
Top Stories: CMS seeks to lower Rx drug costs through price transparency
The rule would allow CMS to have more insight into what the most expensive drugs on the market actually cost to manufacture and distribute.
Photo: Jeff Lagasse/Healthcare Finance News
The federal government wants to drive down prescription drug costs. What's the plan? We'll answer that and other questions in this week's Top Stories, including: How is Bright Heath faring? And what are providers doing with Epic software?
For more news and features from Jeff Lagasse, visit Healthcare Finance News.
In this episode:
- CMS proposes to hold drugmakers and PBMs accountable for cost of drugs covered by Medicaid
- Insurtech company Bright Health finalizes reverse stock split
- 24 health systems join TEFCA via Epic QHIN
Talking points:
- A proposed rule would allow CMS to have more insight into what the most expensive drugs on the market actually cost to manufacture and distribute.
- Medicaid, under the new proposal, would have the increased ability to hold drug manufacturers accountable for what Medicaid programs pay for drugs.
- Bright Health has finalized a 1-to-80 reverse stock split to raise its share price above the threshold required to remain on the New York Stock Exchange.
- A group of providers is pledging to use Epic software to share patient health information through the Trusted Exchange Framework and the Common Agreement in a new agreement with Epic TEFCA Interoperability Services.
Twitter: @JELagasse
Email the writer: Jeff.Lagasse@himssmedia.com
